GD-TOPIRAMATE
GD-TOPIRAMATE
Discontinued
DIN Number
02352885
Drug Class
Human
Market Date
May 10, 2012
Company
HC
genmed a division of pfizer canada ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02352885
AIG Number0132938006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX11 TOPIRAMATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOPIRAMATEActive
Strength: 200 MG
Monograph: TOPIRAMATE